A Deep Dive into Understanding Tumor Foci Classification using Multiparametric MRI Based on Convolutional Neural Network

Data scarcity has refrained deep learning models from making greater progress in prostate images analysis using multiparametric MRI. In this paper, an efficient convolutional neural network (CNN) was developed to classify lesion malignancy for prostate cancer patients, based on which model interpretation was systematically analyzed to bridge the gap between natural images and MR images, which is the first one of its kind in the literature. The problem of small sample size was addressed and successfully tackled by feeding the intermediate features into a traditional classification algorithm known as weighted extreme learning machine, with imbalanced distribution among output categories taken into consideration. Model trained on public data set was able to generalize to data from an independent institution to make accurate prediction. The generated saliency map was found to overlay well with the lesion and could benefit clinicians for diagnosing purpose.

Segmentation of the Prostatic Gland and the Intraprostatic Lesions on Multiparametic MRI Using Mask-RCNN

Prostate cancer (PCa) is the most common cancer in men in the United States. Multiparametic magnetic resonance imaging (mp-MRI) has been explored by many researchers to targeted prostate biopsies and radiation therapy. However, assessment on mp-MRI can be subjective, development of computer-aided diagnosis systems to automatically delineate the prostate gland and the intraprostratic lesions (ILs) becomes important to facilitate with radiologists in clinical practice. In this paper, we first study the implementation of the Mask-RCNN model to segment the prostate and ILs. We trained and evaluated models on 120 patients from two different cohorts of patients. We also used 2D U-Net and 3D U-Net as benchmarks to segment the prostate and compared the model's performance. The contour variability of ILs using the algorithm was also benchmarked against the interobserver variability between two different radiation oncologists on 19 patients. Our results indicate that the Mask-RCNN model is able to reach state-of-art performance in the prostate segmentation and outperforms several competitive baselines in ILs segmentation.